DOJ Unlikely To Take Off-Label Promotion Case To Supreme Court, Attorneys Say

The recent appellate court case U.S. v. Caronia was viewed as a victory for pharmaceutical companies in terms of truthful, off-label promotion, and as the government assesses its next move, attorneys project the case won’t make it to the Supreme Court.